Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.

Zhou X, Su J, Zhu L, Zhang G.

Helicobacter. 2014 Jun;19(3):174-81. doi: 10.1111/hel.12120. Epub 2014 Mar 17. Erratum in: Helicobacter. 2017 Aug;22(4):.

PMID:
24628843
2.

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH, Berns EM, Verweij J, Pothof J, Wiemer EA.

Oncogene. 2013 Sep 5;32(36):4284-93. doi: 10.1038/onc.2012.433. Epub 2012 Oct 8.

PMID:
23045278
3.

MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.

Jiang T, Dong P, Li L, Ma X, Xu P, Zhu H, Wang Y, Yang B, Liu K, Liu J, Xue J, Lv R, Su P, Kong G, Chang Y, Zhao C, Wang L.

Oncol Rep. 2017 Jul;38(1):151-158. doi: 10.3892/or.2017.5659. Epub 2017 May 22.

PMID:
28534959
4.

microRNA-29a-3p, Up-Regulated in Human Gastric Cells and Tissues with H.Pylori Infection, Promotes the Migration of GES-1 Cells via A20-Mediated EMT Pathway.

Sun F, Ni Y, Zhu H, Fang J, Wang H, Xia J, Ding F, Shen H, Shao S.

Cell Physiol Biochem. 2018;51(3):1250-1263. doi: 10.1159/000495502. Epub 2018 Nov 28.

5.

miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.

Cao W, Yang W, Fan R, Li H, Jiang J, Geng M, Jin Y, Wu Y.

Tumour Biol. 2014 Feb;35(2):1287-95. doi: 10.1007/s13277-013-1171-7. Epub 2013 Sep 26.

PMID:
24068565
6.

Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway.

Yang XJ, Si RH, Liang YH, Ma BQ, Jiang ZB, Wang B, Gao P.

World J Gastroenterol. 2016 Apr 21;22(15):3978-91. doi: 10.3748/wjg.v22.i15.3978.

7.

Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.

Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H.

Cancer. 2010 Jan 1;116(1):41-9. doi: 10.1002/cncr.24743.

8.

MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.

Zhou X, Jin W, Jia H, Yan J, Zhang G.

J Exp Clin Cancer Res. 2015 Mar 26;34:28. doi: 10.1186/s13046-015-0145-6.

9.

MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.

Wen L, Cheng F, Zhou Y, Yin C.

Saudi J Gastroenterol. 2015 Sep-Oct;21(5):313-9. doi: 10.4103/1319-3767.166206.

10.

miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.

Yang M, Shan X, Zhou X, Qiu T, Zhu W, Ding Y, Shu Y, Liu P.

Anticancer Agents Med Chem. 2014;14(6):884-91.

PMID:
24875127
11.

miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.

Bao J, Xu Y, Wang Q, Zhang J, Li Z, Li D, Li J.

Biomed Pharmacother. 2017 Aug;92:1030-1037. doi: 10.1016/j.biopha.2017.06.011. Epub 2017 Jun 10.

PMID:
28609840
12.

MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.

Wang T, Ge G, Ding Y, Zhou X, Huang Z, Zhu W, Shu Y, Liu P.

Chin Med J (Engl). 2014;127(12):2357-62.

PMID:
24931256
13.

miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.

Li X, Liang J, Liu YX, Wang Y, Yang XH, Luan BH, Zhang GL, Du J, Wu XH.

Pharmazie. 2016 Nov 2;71(11):640-643. doi: 10.1691/ph.2016.6696.

PMID:
29441968
14.

Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4.

Zhou X, Li L, Su J, Zhang G.

PLoS One. 2014 Jul 1;9(7):e101457. doi: 10.1371/journal.pone.0101457. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e109057.

15.

Down-regulation of miR-141 induced by helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4.

Zhou X, Xia Y, Su J, Zhang G.

Cell Physiol Biochem. 2014;33(4):1003-12. doi: 10.1159/000358671. Epub 2014 Apr 4.

16.

Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway.

Santos JC, Brianti MT, Almeida VR, Ortega MM, Fischer W, Haas R, Matheu A, Ribeiro ML.

Mol Carcinog. 2017 Apr;56(4):1372-1379. doi: 10.1002/mc.22590. Epub 2016 Nov 23.

PMID:
27862371
17.

Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior.

Huang WT, Kuo SH, Cheng AL, Lin CW.

Mod Pathol. 2014 Aug;27(8):1116-25. doi: 10.1038/modpathol.2013.229. Epub 2014 Jan 3.

18.
19.

MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2.

Zhou X, Xia Y, Li L, Zhang G.

Cancer Biol Ther. 2015;16(1):160-9. doi: 10.4161/15384047.2014.987523.

20.

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.

Zhang X, Huang L, Zhao Y, Tan W.

Acta Biochim Biophys Sin (Shanghai). 2013 Dec;45(12):995-1001. doi: 10.1093/abbs/gmt113. Epub 2013 Oct 20.

PMID:
24145606

Supplemental Content

Support Center